This inventor holds 4 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Rafael, CA (US) (2019 - 2022)
- Novato, CA (US) (2022)
Company Filing History:
Years Active: 2019-2022
Title: Saeed Moshashaee: Innovator in Therapeutic Enzyme Research
Introduction
Saeed Moshashaee is a prominent inventor based in San Rafael, CA (US). He has made significant contributions to the field of therapeutic lysosomal enzyme fusion proteins. With a total of 4 patents, his work focuses on innovative solutions for treating lysosomal storage diseases.
Latest Patents
Moshashaee's latest patents include groundbreaking research on targeted therapeutic lysosomal enzyme fusion proteins. This patent relates to therapeutic lysosomal enzyme fusion proteins that are useful for treating lysosomal storage diseases. It also covers liquid formulations comprising such fusion proteins and associated methods for treating these diseases in mammals. Another notable patent is for TPP-1 formulations and methods for treating CLN2 disease. This patent discloses formulations comprising recombinant human tripeptidyl peptidase-1 (rhTPP1) for various administration routes. The methods outlined are effective in halting the progression of CLN2 disease and may be used to treat subjects with CLN2 or a family history of the disease.
Career Highlights
Moshashaee is currently associated with BioMarin Pharmaceutical Inc., where he continues to advance his research in therapeutic applications. His work has been instrumental in developing treatments that address critical health issues related to lysosomal storage diseases.
Collaborations
He collaborates with notable colleagues such as Thomas Lester and Augustus O Okhamafe, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Saeed Moshashaee's contributions to the field of therapeutic enzyme research are noteworthy. His innovative patents and ongoing work at BioMarin Pharmaceutical Inc. highlight his commitment to improving treatments for lysosomal storage diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile